Lebo et al, Cold Spring Harbor Symp. Quant. Biol., 51: 169-176 (1986).* |
Sambrook et al, “Molecular Cloning, A Laboratory Manual, 2nd Edition”; Cold Spring Harbor Laboratory Press, USA (1989) pp 16.3-16.4, 17.2, 15.81-15.84.* |
Kovacs et al, Nature Medicine 2(2) pp 224-229 (1996).* |
Elder et al, J of Neuroscience Research 45: 308-320 (1996).* |
Cook et al, PNAS 93 pp 9223-9228 (1996).* |
Sahara et al, FEBS Letters 381 (1996) 7-11.* |
Gomez-Isla et al, Annals of Neurology 41(6) 809-812 (1997).* |
Baumann et al, Eur J. Biochemistry 52 pp 521-529 (1975).* |
van Bogaert, L. et al., “Sur les formes familiales précoces de la maladie d'Alzheimer,” Mschr. Psych. Neurol. 102:249-301 (1940). |
Walder, R.Y. and J.A. Walder, “Oligodeoxynucleotide-directed mutagenesis using the yeast transformation system,” Gene 42(2):133-139 (1986). |
Boteva, K., et al., “Mutation analysis of presenilin 1 gene in Alzheimer's disease,” Lancet 347(8994):130-131 (Jan., 1996). |
Clark, R.F., et al., “The structure of the presenilin 1 (S182) gene and identification of six novel mutations in early onset AD families,” Nature Gen. 11(2):219-222 (Oct., 1995). |
Sherrington, R., et al., “Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease,” Nature 375(6534):754-760 (Jun., 1995). |
Abraham, C.R. et al., “Immunochemical Identification of the Serine Protease Inhibitor α1-Antichymotrypsin in the Brain Amyloid Deposits of Alzheimer's Disease,” Cell 52(4):487-501 (1988). |
Acsadi, G. et al., “Human dystrophin expression in mdx mice after intramuscular injection of DNA constructs,” Nature 352:815-818 (1991). |
Alber, T. and G. Kawasaki, “Nucleotide Sequence of the Trisoe Phosphate Isomerase Gene of Sacharomyces cerevisiae,” J. Mol. Appl. Genet. 1(5):419-434 (1982). |
Ammer, G., “Expression of Genes in Yeast Using the ADCI Promoter,” Meth. Enzymol. 101:192-201 (1983). |
Atkinson, A.E. et al., “Baculoviruses as Vectors for Foreign Gene Expression in Insect Cells,” Pestic. Sci. 28:215-224 (1990). |
Bauer, C.E. et al., “A genetic enrichment for mutations constructed by oligodeoxynucleotide-directed mutagenesis,” Gene 37:73-81 (1985). |
Beggs, J.D., “Transformation of yeast by a replicating hybrid plasmid,” Nature 275:104-109 (1978). |
Beidler, C.B. et al., “Cloning and High Level Expression of a Chimeric Antibody with Specificity for Human Carcinoembryonic Antigen,” J. Immunol. 141911);4053-4060 (1988). |
Bej, A.K. et al., “Polymerase Chain Reaction-Gene Probe Detection of Microorganisms by Using Filter-Concentrated Samples,” Appl. Environ. Microbiol. 57(12):3529-3534 (1991). |
Benjamin, R. et al., “Protective effect of apoE ε2 in Alzheimer's disease,” Lancet 344:473 (Aug. 1994). |
Bergman, Y. et al., “Two regulatory elements for immunoglobulin κ light chain gene expression,” Proc. Natl. Acad. Sci. 81(22):7041-7045 (1984). |
Better, M. et al., “Escherichia coli Secretion of an Active Chimeric Antibody Fragment,” Science 240:1041-1043 (1988). |
Bird, R.E. et al., “Single-Chain Antigen-Binding Proteins,” Science 242: 423-426 (1988). |
Bird, T.D. et al., “Familial Alzheimer's Disease in American Descendants of the Volga Germans: Probable Genetic Founder Effect,” Ann. Neurol. 23(1):25-31 (1988). |
Bird, T.D. et al., “Phenotypic Heterogeneity in Familial Alzheimer's Disease: A Study of 24 Kindreds,” Ann. Neurol. 25(1):12-25 (1989). |
Blais, B.W., “Transcriptional Enhancement of the Listeria monocytogenes PCR and Simple Immunoenzymatic Assay of the Product Using Anti-RNA:DNA Antibodies,” Appl. Environ. Microbiol. 60(1):348-352 (Jan. 1994). |
Bolivar, F. et al., “Construction and Characterization of New Cloning Vehicles. II. A Multipurpose Cloning System,” Gene 2:95-113 (1977). |
Boshart, M. et al., “A Very Strong Enhancer Is Located Upstream of an Immediate Early Gene of Human Cytomegalovirus,” Cell 41(2):521-530 (1985). |
Botstein, D. et al., “Sterile Host Yeasts (SHY): A Eukaryotic System of Biological Containment for Recombinant DNA Experiments,” Gene 8(1):17-24 (1979). |
Brinster, R.L. et al., “Factors affecting the efficiency of introducing foreign DNA into mice by microinjecting eggs,” Proc. Natl. Acad. Sci. USA 82(13):4438-4442 (1985). |
Brito, G.N.O. et al., “Behavioral Characteristics of Vasopressin-Deficient Rats (Brattleboro Strain),” Brain Res. Bull. 6(1):71-75 (1981). |
Broach, J.R. et al., “Transformation in Yeast: Development of a Hybrid Cloning Vector and Isolation of the CAN1 gene,” Gene 8(1):121-133 (1979). |
Brousseau, T. et al., “Confirmation of the ε4 allele of the apolipoprotein E gene as a risk factor for late onset Alzheimer's disease,” Neurol.44(2):342-344 (Feb. 1994). |
Casadaban, M.J. et al., “In Vitro Gene Fusions That Join an Enzymatically Active β-Galactosidase Segment to Amino-Terminal Fragments of Exogenous Proteins: Escherichia coli Plasmid Vectors for the Detection and Cloning of Translational Initiation Signals,” J. Bacteriol. 143(2):971-980 (1980). |
Cataldo, A.M. et al., “Lysosomal proteinase antigens are prominently located within senile plaques of Alzheimer's disease: evidence for a neuronal origin,” Brain Res. 513(2):181-192 (1990). |
Chang, A.C.Y. et al., “Phenotypic expression in E. coli of a DNA sequence coding for mouse dihydrofolate reductase,” Nature 275:617-624 (1978). |
Choi-Miura, N.-H. et al., “SP-40,40 is a constituent of Alzheimer's Amyloid,” Acta Neuropathol. 83(3):260-264 (1992). |
Cook, R.H. et al., “Studies in aging of the brain: IV. Familial Alzheimer disease: Relation to transmissible dementia, aneuploidy, and microtubular defects,” Neurol. 29(10):1402-1412 (1979). |
Corder, E.H. et al., “Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families,” Science 261:921-923 (1993). |
Corder, E.H. et al., “Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer Disease,” Nature Genet. 7(2):180-184 (Jun. 1994). |
Coria, F. et al., “Isolation and Characterization of Amyloid P Component from Alzheimer's Disease and Other Types of Cerebral Amyloidosis,” Lab. Invest. 58(4):454-458 (1988). |
Corsaro, C.M. and M.L. Pearson, “Enhancing the Efficiency of DNA-Mediated Gene Transfer in Mammalian Cells,” Somatic Cell Genet. 7(5):603-616 (1981). |
Craik, C.S., “Use of Oligonucleotides for Site-Specific Mutagenesis,” BioTech. 3(1):12-19 (1985). |
Cristiano, R.J. et al., “Hepatic gene therapy: Adenovirus enhancement of receptor-mediated gene delivery and expression in primary hepatocytes,” Proc. Natl. Acad. Sci. USA 90(6):2122-2126 (1993). |
Cullen, D. et al., “Controlled Expression and Secretion of Bovine Chymosin in Aspergillus nidulans,” Bio/technol. 5:369-376 (1987). |
Curiel, D.T. et al., “High-Efficiency Gene Transfer Mediated by Adenovirus Coupled to DNA-Polylysine Complexes,” Hum. Gene Ther. 3(2):147-154 (1992). |
Czakó, M. and L. Màrton, “The Herpes Simplex Virus Thymidine Kinase Gene as a Conditional Negative-Selection Marker Gene in Arabidopsis thaliana,” Plant Physiol. 104(3):1067-1071 (Mar. 1994). |
DeNoto, F.M. et al., “Human growth hormone DNA sequence and mRNA structure: possible alternative splicing,” Nucl. Acids Res. 9(15):3719-3730 (1981). |
Drinkwater, N.R. and D.K. Klinedinst, “Chemically induced mutagenesis in a shuttle vector with a low-background mutant frequency,” Proc. Natl. Acad. Sci. USA 83(10):3402-3406 (1986). |
Duplàa, C. et al., “Quantitative Analysis of Polymerase Chain Reaction Products Using Biotinylated DuTP Incorporation,” Analyt. Biochem. 212(1):229-236 (1993). |
Elvin, C.M. et al., “Modified bacteriophage lambda promoter vectors for overproduction of proteins in Escherichia coli,” Gene 87(1):123-126 (1990). |
Feldman, R.G. et al., “Familial Alzheimer's Disease,” Neurol. 13(10):811-824 (1963). |
Felgner, P.L. et al., “Lipofection: A highly efficient, Lipid-mediated DNA-transfection procedure,” Proc. Natl. Acad. Sci. USA 84(21):7413-7417 (1987). |
Gershon, S. et al., “Methods for the Evaluation of Pharmacologic Agents in the Treatment of Cognitive and Other Defects in Dementia,” in: Clinical Evaluation of Psychotropic Drugs: Principles and Guidelines, Prien, R.F. and D.S. Robinson, eds., Raven Press, Ltd., New York, NY, pp. 467-499 (Sep. 1994). |
Gillies, S.D. et al., “A Tissue-specific Transcription Enhancer Element Is Located in the Major Intron of a Rearranged Immunoglobulin Heavy Chain Gene,” Cell 33(3):717-728 (1983). |
Glasky, M.S. and C.L. Reading, “Stability of Specific Immunoglobulin Secretion by EBV-Transformed Lymphoblastoid Cells and Human-Murine Heterohybridomas,” Hybridoma 8(4):377-389 (1989). |
Goate, A. et al., “Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease,” Nature 349:704-706 (1991). |
Gold, L. et al., “Translational Initiation in Prokaryotes,” Ann. Rev. Microbiol. 35:365-403 (1981). |
Goudsmit, J. et al., “Familial Alzheimer's Disease in Two Kindreds of the Same Geographic and Ethnic Origin: A Clinical and Genetic Study,” J. Neurolog. Sci. 49(1):79-89 (1981). |
Graham, F.L. et al., “Characteristics of a Human Cell Line Transformed by DNA from Human Adenovirus Type 5,” J. Gen. Virol. 36(1):59-72 (1977). |
Graham, F.L. and A.J. Van der Eb, “A New Technique for the Assay of Infectivity of Human Adenovirus 5 DNA,” Virol. 52(2):456-467 (1973). |
Grant, F.J. et al., “Improved RNA sequencing method to determine immunoglobulin mRNA sequence,” Nucl. Acids Res. 15(13):5496 (1987). |
Hammer, R.E. et al., “Production of transgenic rabits, sheep and pigs by microinjection,” Nature 315:680-683 (1985). |
Hamos, J.E. et al., “Expression of heat shock proteins in Alzheimer's disease,” Neurol. 41(2):345-350 (1991). |
Heston, L.L. and J. White, “Pedigrees of 30 Families with Alzheimer Disease: Associations with Defective Organization of Microfilaments and Microtubules,” Behaviol Genet. 8(4):315-331 (1978). |
Hinnen, A. et al., “Transformation of yeast,” Proc. Natl. Acad. Sci. USA 75(4):1929-1933 (1978). |
Hitzeman, R.A. et al., “Isolation and Characterization of the Yeast 3-Phosphoglycerokinase Gene (PGK) by an Immunological Screening Technique,” J. Biol. Chem. 255(24):12073-12080 (1980). |
Horwitz, M.S.Z. et al., “Selection of new biological activities from random nucleotide sequences: evolutionary and practical considerations,” Genome 31(1):112-117 (1989). |
Hurby, V.J. et al., “Application of Synthetic Peptides: Antisense Peptides,” in: Synthetic Peptides: A User's Guide, Grant, G.A., ed., W.H. Freeman, New York, NY, pp. 289-307 (1992). |
Iida, K. et al., “Rapid and sensitive method for detection of Salmonella strains using a combination of polymerase chain reaction and reverse dot-blot hybridization,” FEMS Microbiol. Letts. 114(2):167-172 (1993). |
Ito, H. et al., “Transformation of Intact Yeast Cells Treated with Alkali Cations,” J. Bacteriol. 153(1):163-168 (1983). |
Jasny, B.R., “Insect Viruses Invade Biotechnology,” Science 238:1653 (1987). |
Jones, P.T. et al., “Replacing the complementarity-determining regions in a human antibody with those from a mouse,” Nature 321:522-525 (1986). |
Kamino, K. et al., “Linkage and Mutational Analysis of Familial Alzheimer Disease Kindreds for the APP Gene Region,” Am. J. Hum. Genet. 51(5):998-1014 (1992). |
Kasprzak, A.A. et al., “Location of a Contact Site between Actin and Myosin in the Three-Dimentional Structure of the Acto-S1 Complex,” Biochem. 28:9230-9238 (1989). |
Koering, C.E. et al., “Induced Expression of the Conditionally Cytotoxic Herpes Simplex Virus thymidine kinase Gene by Means of a Parvoviral Regulatory Circuit,” Hum. Gene Ther. 5(4): 457-463 (Apr. 1994). |
Kramer, F.R. and P.M. Lizardi, “Replicatable RNA reporters,” Nature 339:401-402 (1989). |
Kuusisto, J. et al., “Association of apolipoprotein E phenotypes with late onset Alzheimer's disease: population dased study,” British Med. J. 309:636-638 (Sep. 1994). |
Kyte, J. and R.F. Doolittle, “A Simple Method for Displaying the Hydropathic Character of a Protein,” J. Mol. Biol. 157(1):105-132 (1982). |
Lannfelt, L. et al., “No linkage to chromosome 14 in Swedish Alzheimer's disease families,” Nature Genet. 4(3):218-219 (1993). |
Levy-Lahad, E. et al., “Candidate Gene for the Chromosome 1 Familial Alzheimer's Disease Locus,” Science 269:973-977 (Aug. 1995). |
Liao, X. and J.A. Wise, “A simple high-efficiency method for random mutagenesis of cloned genes using forced nucleotide misincorporation,” Gene 88(1):107-111 (1990) |
Liddell, M. et al., “Confirmation of association between the e4 allele of apolipoprotein E and Alzheimer's disease,” J. Med. Genet. 31(3):197-200 (Mar. 1994). |
Liu, A.Y. et al., “Production of a Mouse-Human Chimeric Monoclonal Antibody to CD20 with Potent Fc-Dependent Biologic Activity,” J. Immunol. 139(10):3521-3526 (1987). |
Liu, A.Y. et al., “Chimeric mouse-human IgG1 antibody that can mediate lysis of cancer cells,” Proc. Natl. Acad. Sci. USA 84(10):3439-3443 (1987). |
Lizardi, P.M. et al., “Exponential Amplification of Recombinant-RNA Hybridization Probes,” Bio/Technol. 6:1197-1202 (1988). |
Loh, D.Y. et al., “Molecular Basis of a Mouse Strain-Specific Anti-Hapten Response,” Cell 33(1):85-93 (1983). |
Lomeli, H. et al., “Quantitative Assays Based on the Use of Replicatable Hybridization Probes,” Clin. Chem. 59(9):1826-1831 (1989). |
Martin, J.J. et al., “Early-onset Alzheimer's disease in 12 large Belgian families,” Neurol. 41(1):62-68 (1991). |
McGeer, P.L. et al., “Distribution of clusterin in Alzheimer brain tissue,” Brain Res. 579(2):337-341 (1992). |
McGeer, P.L. and J. Rogers, “Anti-inflammatory agents as a therapeutic approach to Alzheimer's disease,” Neurol. 42(2):447-449 (1992). |
McKnight, G.L. et al., “Identification and molecular analysis of a third Aspergillus nidulans alcohol dehydrogenase gene,” EMBO J. 4(8):2093-2099 (1985). |
Messing, J., “New M13 Vectors for Cloning,” Meth. Enzymol. 101:20-78 (1983). |
Miller, D.W. et al., “An Insect Baculovirus Host-Vector System for High-Level Expression of Foreign Genes,” in: Genetic Engineering Principles and Methods vol. 8, Setlow, J.K. and A. Hollaender, eds., Plenum Press, New York, NY, 277-298 (1986). |
Morrison, S.L., “Transfectomas Provide Novel Chimeric Antibodies,” Science 229:1202-1207 (1985). |
Namba, Y. et al., “Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease,” Brain Res. 541(1):163-166 (1991). |
Nee, L.E. et al., “Dememtia of the Alzheimer type: Clinical and family study of 22 twin pairs,” Neurol. 37:359-363 (1987). |
Nee, L.E. et al., “A Family With Histologically Confirmed Alzheimer's Disease,” Arch. Neurol. 40(4):203-208 (1983). |
Neumann, E. et al., “Gene transfer into mouse lyoma cells by electroporation in high electric fields,” EMBO J. 1(7):841-845 (1982). |
Nichols, B.P. and C. Yanofsky, “Plasmids Containing the trp Promoters of Escherichia coli and Serratia marcescens and Their Use in Expressing Cloned Genes,” Meth. Enzymol. 101:155-164 (1983). |
Nickerson, D.A. et al., “Automated DNA diagnostics using an ELISA-based oligonucleotide ligation assay,” Proc. Natl. Acad. Sci. USA 87(22):8923-8927 (1990). |
Nishimura, Y. et al., “Recombinant Human-Mouse Chimeric Monoclonal Antibody Specific for Common Acute Lymphocytic Leukemia Antigen,” Cancer Res. 47:999-1005 (1987). |
Ohno, T. et al., “Gene Therapy for Vascular Smooth Muscle Cell Proliferation After Arterial Injury,” Science 265:781-784 (Aug. 1994). |
Oi, V.T. and S.L. Morrison, “Chimeric Antibodies,” BioTechniques 4(3):214-221 (1986). |
Ørskov, C. and J.H. Nielsen, “Truncated glucagon-like peptide-1 (proglucagon 78-107 amide), an intestinal insulin-releasing peptide, has specific receptors on rat insulinoma cells (RIN 5AH),” FEBS Letts. 229(1):175-178 (1988). |
Palmiter, R.D. et al., “Metallothionein-Human GH Fusion Genes Stimulate Growth of Mice,” Science 222:809-814 (1983). |
Palmiter, R.D. and R.L. Brinster, “Transgenic Mice,” Cell 41(2):343-345 (1985). |
Paszkowski, J. et al., “Direct Gene Transfer to Plants,” EMBO J. 3:2717-2722 (1984). |
Pericak-Vance, M.A. et al., “Genetic Linkage Studies in Alzheimer's Disease Families,” Exper. Neurol. 102(3):271-279 (1988). |
Pickering, J.G. et al., “Liposome-Mediated Gene Transfer into Human Vascular Smooth Muscle Cells,” Circulation 89(1):13-21 (Jan. 1994). |
Queen, C., “A Vector That Uses Phage Signals for Efficient Synthesis of Proteins in Escherichia coli,” J. Mol. Appl. Genet. 2(1):1-10 (1983). |
Rapoport, S.I. et al., “Discordance and concordance of dementia of the Alzheimer type (DAT) in monozygotic twins indicate heritable and sporadic forms of Alzheimer's disease,” Neurol. 41(10):1549-1553 (1991). |
Rubin, G.M., “Drosophila melanogaster as an Experimental Organism,” Science 240:1453-1459 (1988). |
Russell, D.R. and G.N. Bennett, “Construction and analysis of in vivo activity of E. coli promoter hybrids and promoter mutants that alter the −35 to −10 spacing,” Gene 20(2):231-243 (1982). |
Russell, P.R., “Evolutionary divergence of the mRNA transcription initiation mechanism in yeast,” Nature 301:167-169 (1983). |
Schellenberg, G.D. et al., “Absence of Linkage of Chromosome 21q21 Markers to Familial Alzheimer's Disease,” Science 241:1507-1510 (1988). |
Schellenberg, G.D. et al., “Linkage Analysis of Familial Alzheimer Disease, Using Chromosome 21 Markers,” Am. J. Hum. Genet. 48:563-583 (1991). |
Schellenberg, G.D. et al., “APP717, APP693, and PRIP Gene Mutations Are Rare in Alzheimer Disease,” Am. J. Hum. Genet. 49:511-517 (1991). |
Schellenberg, G.D. et al., “Genetic Linkage Evidence for a Familial Alzheimer's Disease Locus on Chromosome 14,” Science 258:668-671 (1992). |
Schellenberg, G.D. et al., “Genetic Association and Linkage Analysis of the Apolipoprotein CII Locus and Familial Alzheimer's Disease,” Ann. Neurol. 31:223-227 (1992). |
Schellenberg, G.D. et al., “Chromosome 14 and Late-Onset Familial Alzheimer Disease (FAD),” Am. J. Hum. Genet. 53:619-628 (1993). |
Shaw, D.R. et al., “Mouse/Human Chimeric Antibodies to a Tumor-Associated Antigen: Biologic Activity of the Four Human IgG Subclasses,” J. Natl. Cancer Inst. 80(19):1553-1559 (1988). |
Smith, A.D. et al., “Protective effect of apoE ε2 in Alzheimer's disease,” Lancet344:473-474 (Aug. 1994). |
Stewart, C.A. and R.G.M. Morris, “The watermaze,” in: Behavioral Neuroscience, A Practical Approach, vol. I, Sahgal, A., ed. IRL Press, Oxford, pp. 107-122 (1993). |
Strauss, S. et al., “Detection of Interleukin-6 and α2-Macroglobulin Immunoreactivity in Cortex and Hippocampus of Alzheimer's Disease Patients,” Lab. Invest. 66(2):223-230 (1992). |
Struhl, K. et al., “High-frequency transformation of yeast: Autonomous replication of hybrid DNA molecules,” Proc. Natl. Acad. Sci. USA 76(3):1035-1039 (1979). |
Studier, F.W. et al., “Use of T7 RNA Polymerase to Direct Expression of Cloned Genes,” Meth. Enzymol. 185:60-89 (1990). |
Subramani, S. et al., “Expression of the Mouse Dihydrofolate Reductase Complementary Deoxyribonucleic Acid in Simian Virus 40 Vectors,” Mol. Cell. Biol. 1(9):854-864 (1981). |
Sun, L.K. et al., “Chimeric antibody with human constant regions and mouse variable regions directed against carcinoma-associated antigen 17-1A,” Proc. Natl. Acad. Sci. USA 84(1):214-218, (1987). |
Tsai, M.-S. et al., “Apolipoprotein E: Risk Factor for Alzheimer Disease,” Am. J. Hum. Genet. 54:643-649 (Apr. 1994). |
Turnbull, I.F. et al., “Expression of the Escherichia coli Entertoxin Subunit B Gene in Aspergillus nidulans Directed by the AMDS Promoter,” Bio/Technol. 7:169-174 (1989). |
Uéda, K. et al., “Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease,” Proc. Natl. Acad. Sci. USA 90(23):11282-11286 (1993). |
van Duijn, C.M. et al., “A Population-based Study of Familial Alzheimer Disease: Linkage to Chromosomes 14, 19, and 21,” Am. J. Hum. Genet. 55:714-727 (Oct. 1994). |
Verhoeyen, M. et al., “Reshaping Human Antibodies: Grafting an Antilysozyme Activity,” Science 239:1534-1536 (1988). |
Vieira, J. and J. Messing, “The pUC plasmids, an M13mp7-derived system for insertion mutagenesis and sequencing with synthetic universal primers,” Gene 19:259-268 (1982). |
Vile, R.G. and I.R. Hart, “Use of Tissue-specific Expression of the Herpes Simplex Virus Thymiding Kinase Gene to Inhibit Growth of Established Murine Melanomas following Direct Intratumoral Injection of DNA,” Cancer Res. 53(17):3860-3864 (1993). |
Wang, C.-Y. and L. Huang, “pH-sensitive immunoliposomes mediate target-cell-specific delivery and controlled expression of a foreign gene in mouse,” Proc. Natl. Acad. Sci. USA 84(22):7851-7855 (1987). |
Wheelan, L., “Familiar Alzheimer's Disease,” Ann. Hum. Genet 23(3):300-310 (1959). |
Wigler, M. et al., “Biochemical Transfer of Single-Copy Eucaryotic Genes Using Total Cellular DNA as Donor,” Cell 14(3):725-731 (1978). |
Williams, R.S. et al. “Introduction of foreign genes into tissues of living mice by DNA-coated microprojectiles,” Proc. Natl. Acad. Sci. USA 88(7):2726-2730 (1991). |
Wisniewski, T. and B. Frangione, “Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid,” Neurosci. Letts. 135:235-238 (1992). |
Wood, C.R. et al., “The synthesis and in vivo assembly of functional antibodies in yeast,” Nature 314:446-449 (1985). |
Wu, C.H. et al., “Targeting Genes: Delivery and Persistant Expression of a Foreign Gene Driven by Mammalian Regulatory Elements in vivo,” J. Biol. Chem 264(29):16985-16987 (1989). |
Yelton, M.M. et al., “Transformation of Alpergillus nidulans by using a trpC plasmid,” Proc. Natl. Acad. Sci. USA 81(5):1470-1474 (1984). |
Yu, C.-E. et al., “The Apolipoprotein E/CI/CII Gene Cluster and Late-Onset Alzheimer Disease,” Am. J. Hum. Genet. 54:631-642 (Apr. 1994). |